Fiducial Markers Market: Regional Growth Trends Focusing on Manufacturers Recorded during 2019-2028

Posted on 2019-09-05 by Mark Hub in Healthcare // 0 Comments

Albany, US, 2019-Sep-05 — /EPR Network/ —

Eckert & Ziegler BEBIG entered into an agreement with RaySearch Laboratories in the year 2018. With this agreement, Eckert & Ziegler BEBIG aims to leverage new opportunities in the field of brachytherapy- the treatment of prostate cancer through insertion of implants.
Boston Scientific agreed on a $4.24 billion deal to acquire BTG plc, a company offering products for minimally-invasive procedures for treating cancer and vascular diseases, in the year 2018. This acquisition was aimed at bolstering the organization’s capabilities in interventional medicine.

Request TOC of this Report- https://www.factmr.com/report/1026/fiducial-marker-market#rep_toc

The report on fiducial markers also features various other companies operating in the global market space. The other players profiled in the report include Innovative Oncology Solutions, Best Medical International, Inc., Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi Radiotherapy A/S, and Stellar Medical.

Tier 3 Players Account for a Hefty Revenue Share; Product Innovation a Key Focus Area

The tier 1 players in the fiducial markers market hold around 60-70% revenue share. The growth of tier 1 players can be accredited to their robust product portfolios and differentiated strategies in tune with changing nature of the market and evolving end-user specifications.

With persistent focus on effective devices, offering accuracy and precision in the healthcare space, the tier 1 companies in the fiducial markers market are focused on novel product developments taking usability to the next level. Continual emphasis on product developments and innovations enables these players to retain their brand equity and solidify their sustenance in the global market space.

Rising Inclination toward Minimally Invasive Procedures to Hamper Adoption

The preference for minimally invasive procedures is on a continual rise by virtue of lessened pain and minimum risk of infection associated. As per a revelation by the National Health Service (NHS), cancer patients requiring radiotherapy or brachytherapy are highly oriented toward minimally invasive procedures to experience a pain-free diagnosis.

Interventions making use of fiducial markers are invasive in nature and entails a surgery for appropriate positioning of the marker, which is a key factor that might hinder the adoption rate. The increasing embracement of minimally invasive procedures is taking its toll on the adoption rate of fiducial markers, which involves an implantation procedure for target localizing.

Fiducial Markers Surge in Popularity as a Standard Tool for Image-Guided Radiotherapy (IGRT)

Fiducial markers are gaining immense traction as a standard tool for image-guided radiotherapy (IGRT), owing to enhanced precision in terms of results. Acting as reliable surrogates for effectively imaging the anatomic structures, fiducial markers are evolving as an imperative for modern radiotherapy that rapidly resorting to conformal delivery techniques.

With conventional procedures overshadowing imaging accuracy, fiducial markers evolved as a new breakthrough that enabled doctors to have a target area within the field of view and ensure accurate results. In case of prostate cancer cases with floating nature of tumors, fiducial markers are being increasingly adopted for effective diagnosis with optimal accuracy and precision.

To know more about the Fiducial Markers Market, Visit the link- https://www.factmr.com/report/1026/fiducial-marker-market

Rise in Demand for MRI Non-Magnetic Fiducial Markers – A Prominent Trend

Magnetic resonance imaging technique remains a popular technique used in case of radiology. This specialized technique necessitates use of tools and markers that are highly compatible. Many devices and markers, including fiducial markers, which are commercially sold, undergo MRI evaluations with respect to various safety issues and artifacts.

Presence of immoderate ferromagnetism that confine or obscure the target area is one of the primary reasons making commercially available devices unsuitable for MR-guided biopsy sessions. To overcome this, manufacturers are focusing on using materials with low magnetic susceptibility during manufacturing, in order to enhance compatibility of their products with MR-guided procedures. MRI compatible fiducial markers are usually longer than the standard variant, which minimizes the use of multiple needle sticks involved. Moreover, innovative designs used in case of MRI non-magnetic fiducial markers curb bending issues whilst injection processes, unlike the other linear tissue markers.

To get more insights on the dynamics of fiducial markers market,

Fiducial Markers Market Structure

The fiducial markers market has been segmented on the basis of product type, modality, disease sites, end users, and region. By product type, polymer-based fiducial markers, metal-based fiducial markers, pure gold fiducial markers, and liquid fiducial markers. By modality, the fiducial markers market has been segmented into photon therapy, proton therapy, tomotherapy, and cyberknife. By disease sites, the fiducial markers market has been segmented into head and neck, breast, lungs, abdomen, prostrate, kidney, cervix or other gynecologic organs.

Fiducial Markers- Definition

Fiducial markers refer to objects that are placed in the vicinity of an imaging system framework, which further appears in the image produced. Fiducial markers are placed near or on the tumor to guide the placement of the radiation beams during the radiation treatment.

Request Sample of this Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1026

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick